Success or Failure of High-Flow Nasal Oxygen Therapy: The ROX Index Is Good, but a Modified ROX Index May Be Better
- PMID: 30896964
- PMCID: PMC6603054
- DOI: 10.1164/rccm.201902-0419LE
Success or Failure of High-Flow Nasal Oxygen Therapy: The ROX Index Is Good, but a Modified ROX Index May Be Better
Comment in
-
Reply to Tatkov, to Karim and Esquinas, and to Tulaimat.Am J Respir Crit Care Med. 2019 Jul 1;200(1):117-119. doi: 10.1164/rccm.201903-0571LE. Am J Respir Crit Care Med. 2019. PMID: 30896963 Free PMC article. No abstract available.
Comment on
-
An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC. Am J Respir Crit Care Med. 2019. PMID: 30576221
References
-
- Kang BJ, Koh Y, Lim CM, Huh JW, Baek S, Han M, et al. Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med. 2015;41:623–632. - PubMed
-
- Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high flow therapy. Am J Respir Crit Care Med. [online ahead of print] 21 Dec 2018; DOI: 10.1164/rccm.201803-0589OC. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources